Cryo-Cell International, Inc. Quarterly report pursuant to Section 13 or 15(d)

Quarterly report pursuant to Section 13 or 15(d)

Description of Business, Basis of Presentation and Significant Accounting Policies - Additional Information (Detail)

Description of Business, Basis of Presentation and Significant Accounting Policies - Additional Information (Detail)				1 Months Ended	3 Months Ended			9 Months Ended
	Jun. 11, 2018	Jun. 01, 2017 USD ($)	Feb. 01, 2012 USD ($)	Dec. 31, 2005 USD ($)	Aug. 31, 2022 USD ($)	Nov. 30, 2021 USD ($)	Aug. 31, 2021 USD ($)	Aug. 31, 2022 USD ($) Unit	Aug. 31, 2021 USD ($)	Apr. 08, 2022 shares	Feb. 28, 2022
Business, Basis of Presentation and Significant Accounting Policies [Line Items]
Deferred revenue					$ 44,218,171			$ 44,218,171
Warranty payment		$ 100,000	$ 75,000	$ 50,000
Commission paid					11,151		$ 12,678	38,471	$ 34,383
Additional capitalized contract acquisition costs, net of amortization expense					29,269		26,410	1,028	72,147
Impairment of contract assets					0			0
Impairment of public inventory						$ 1,164,499
Uncertain tax provisions					0			0
Provisions for interest or penalties related to uncertain tax positions								0	0
Impairment on long lived assets					0		0	0	0
Stock-based option compensation expense					161,000		81,000	311,000	234,000
Unrealized Gain Loss on Marketable Securities					11,000		1,000	38,000	14,000
Derivative, notional amount					$ 8,960,000			$ 8,960,000
Fixed interest rate					6.09%			6.09%
Gain on interest rate swap					$ 62,835		$ 0	$ 62,835	$ 0
Payment warranty				$ 50,000
Increased payment warranty		$ 100,000	$ 75,000
Common Stock Issued \| shares										1,500,000
Cord:Use [Member]
Business, Basis of Presentation and Significant Accounting Policies [Line Items]
Acquisition date	Jun. 11, 2018
Duke University [Member]
Business, Basis of Presentation and Significant Accounting Policies [Line Items]
Contracted storage amortization period											16 years
Umbilical Cord Blood and Cord Tissue Stem Cell Service and PrepaCyte-CB [Member] \| Duke University [Member]
Business, Basis of Presentation and Significant Accounting Policies [Line Items]
Agreement expiration date								Jan. 31, 2025
Inventory, in units \| Unit								6,000
Number of units, per month \| Unit								12
Maximum [Member] \| Umbilical Cord Blood and Cord Tissue Stem Cell Service and PrepaCyte-CB [Member] \| Duke University [Member]
Business, Basis of Presentation and Significant Accounting Policies [Line Items]
Inventory, in units \| Unit								144
Accounts Receivables [Member]
Business, Basis of Presentation and Significant Accounting Policies [Line Items]
Period of doubtful for accounts receivable due from client								30 days
Option One [Member]
Business, Basis of Presentation and Significant Accounting Policies [Line Items]
Contracted storage amortization period					21 years			21 years
Option Two [Member]
Business, Basis of Presentation and Significant Accounting Policies [Line Items]
Contracted storage amortization period					1 year			1 year
Option Three [Member]
Business, Basis of Presentation and Significant Accounting Policies [Line Items]
Contracted storage amortization period								life-time
Contracted storage amortization description								The life-time storage plan is based on a life expectancy of 81 years, which is the current estimate by the Center for Disease Control for United States women’s life expectancy and concluded that additional data analysis would result in an immaterial difference in revenue.